Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants
2023 · Nature Communications · 17 citations
https://doi.org/10.1038/s41467-023-37290-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
249
Citations
7
h-index
7
i10-index
Hasan Uğurlu is an academic researcher from University of Helsinki. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 7, co-authored 18 publications.
ORCID: 0000-0002-3849-7847https://doi.org/10.1038/s41467-023-37290-6
https://doi.org/10.1016/j.str.2022.03.006
Click to start Chat